AVS Biomaterials Interface Division Technical Program Support

描述（由申请人提供）：该R13提案由项目主席（作为项目负责人）提出，旨在获得生物材料界面部（BID）技术会议项目（AVS第53届国际研讨会和展览将于2006年11月12日至17日在旧金山莫斯科尼会议中心举行）上选定的初级和少数族裔讲台演讲者的支持，以及3名研究生海报研究展示奖。今年的BID技术会议的主题集中在表征和控制生物与材料，表面和结构的相互作用方面的进展和创新，跨越几个尺度制度，从宏观到纳米。该课程的设计保持了其高度重视的传统，汇集了世界知名的科学家，生物工程师和临床医生，他们都在寻求理解生物界面研究和技术背景下以材料为中心的问题。我召开这次会议的具体目的是：1)提供丰富多样的科学计划，重点关注在几个生物医学和诊断领域限制生物材料和生物技术生物性能的基本现象（即，向转化研究移动的障碍），以及材料的关键领域-生物相互作用，研究人员正在为生物技术（例如，生物测定，传感）或更临床相关的(植入材料，药物输送，成像，从表面，分析，材料工程和/或生物学角度使用新方法的组织工程问题；2)召集一群演讲者和参与者，包括广泛认可的思想领袖，以及以其工作的新颖性和质量而闻名的年轻、进取和充满活力的教师。演讲者和会议主席将代表学术和商业研究成果，包括诊断和成像专家，生物工程师和基础表面和材料科学家，他们都在生物材料和药物输送，成像技术，诊断方法，设备和组织工程领域工作。重点将放在初级参加者和参与这些领域的人口中代表性不足的部分。这个小组将同样代表在这些领域工作的教师的性别多样性特征；3)促进在生物材料、表面分析、微型化、诊断、给药、MEMs和生物工程领域的初级和代表性不足的少数科学家和教师与该领域著名的高级和国际研究人员之间的互动。来自这些技术领域的公司的一些相关的领先科学家和工程师也被招募参加新的“商业挑战”领奖台机会。

DESCRIPTION (provided by applicant): This R13 proposal by the Program Chair (as PI) seeks support of selected junior and minority-class podium speakers, and 3 graduate student poster research presentation awards at the Biomaterials Interfaces Division (BID) Technical Meeting program, part of the AVS 53rd International Symposium and Exhibition occurring November 12- 17, 2006 at the Moscone Convention Center, San Francisco, CA. The general theme of this year's BID technical conference is centered on progress and innovations in characterization and control of biological interactions with materials, surfaces and structures, across several scaling regimes, from the macroscopic to nanoscopic. The program design keeps with its highly regarded tradition in bringing together world-renowned scientists, bioengineers and clinicians all seeking to understand materials- centered issues in the context of bio-interfacial research and technology. My specific aims in assembling this meeting are to: 1) Provide a rich, diverse scientific program focusing on both fundamental phenomena that constrain bio-performance of biomaterials and biotechnology in several biomedical and diagnostic arenas (i.e., hurdles of moving toward translational research), as well as key areas of materials- biology interactions where investigators are engineering solutions to either biotechnological (e.g., bio-assay, sensing) or more clinically relevant (implant materials, drug delivery, imaging, tissue engineering) problems using novel approaches from a surface, analytical, materials engineering and/or biological perspective; 2) Gather a group of presenters and participants comprising widely acknowledged thought-leaders as well as younger, aggressive, and vibrant faculty already notable for the novelty and quality of their work. Speakers and session chairs will represent both academic and commercial research efforts, comprising diagnostic and imaging experts, bioengineers, and basic surface and materials scientists all working in this area of biomaterials and drug delivery, imaging techniques, diagnostic methods, device and tissue engineering. Emphasis will be placed on junior participants and under-represented components of the population involved in these areas. This group will similarly represent the gender diversity characteristic of faculty working in these areas; 3) Facilitate interactions between junior and under-represented minority scientists and faculty working in the biomaterials, surface analytical, miniaturization, diagnostic, drug delivery, MEMs and bioengineering areas with prominent senior and international investigators in the field. A number of relevant leading scientists and engineers from companies working in these technology areas are also recruited to participate using the new "Commercial Challenge" podium opportunity.